Brief: Idera Pharmaceuticals Inc Files Prospectus Supplement Related To Issuance And Sale Of Up To $35 Million Shares Of Common Stock
March 6 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS INC FILES PROSPECTUS SUPPLEMENT
RELATED TO
ISSUANCE AND SALE OF UP TO $35 MILLION OF SHARES OF COMMON STOCK
- SEC FILING
Source text: (https://bit.ly/2HnCvOV)
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary